Announcements Trials

Browse Landscape

Phase

Phase NA 3 Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 26 Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Prostatic Neoplasms 8 Multiple Myeloma 8 Lung Neoplasms 7 Melanoma 5 Leukemia, Myeloid, Acute 5 Neoplasm Metastasis 4 Glioma 4 Colorectal Neoplasms 4 Carcinoma, Hepatocellular 4 Tuberous Sclerosis 3 Stomach Neoplasms 3 Sarcoma 3 Papillomavirus Infections 3 Leiomyoma 3 Hematologic Neoplasms 3 Glioblastoma 3 Carcinoma, Renal Cell 3 Venous Thromboembolism 2 Rectal Neoplasms 2 Polycythemia Vera 2 Pain 2 Ovarian Neoplasms 2 Oligodendroglioma 2 Obesity 2 Neoplasms by Site 2 Myasthenia Gravis 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Medication Adherence × 90 days × Clear all

NCT07630948 2026-06-05

riboADHERE

Institute of Oncology Ljubljana

Phase 4 Not yet recruiting

Breast Neoplasms, Medication Adherence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡